HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Harold E Bays Selected Research

colesevelam (Welchol)

1/2012Long-term (52-78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients.
11/2011Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
10/2008Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
11/2007The 'forgotten' bile acid sequestrants: is now a good time to remember?
7/2007Rationale and design of a prospective clinical trial program to evaluate the glucose-lowering effects of colesevelam HCl in patients with type 2 diabetes mellitus.
4/2006Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Harold E Bays Research Topics

Disease

19Dyslipidemias (Dyslipidemia)
11/2014 - 03/2002
11Hypercholesterolemia
10/2014 - 11/2002
10Coronary Disease (Coronary Heart Disease)
11/2014 - 07/2004
8Hypertriglyceridemia
05/2015 - 11/2002
8Type 2 Diabetes Mellitus (MODY)
01/2015 - 07/2007
7Flushing
09/2012 - 03/2003
6Cardiovascular Diseases (Cardiovascular Disease)
11/2015 - 03/2008
6Diabetes Mellitus
03/2015 - 09/2007
4Overweight
04/2014 - 09/2009
3Atherosclerosis
03/2015 - 03/2007
3Hypertension (High Blood Pressure)
03/2015 - 04/2008
3Obesity
11/2014 - 08/2004
3Muscular Diseases (Myopathy)
11/2014 - 04/2006
3Metabolic Diseases (Metabolic Disease)
03/2011 - 01/2009
2Body Weight (Weight, Body)
04/2014 - 09/2009
2Hypertrophy
07/2013 - 01/2009
2Insulin Resistance
01/2013 - 03/2007
2Weight Loss (Weight Reduction)
03/2011 - 11/2009
2Hyperlipidemias (Hyperlipidemia)
04/2006 - 11/2002
1Infection
04/2014
1Hypoglycemia (Reactive Hypoglycemia)
01/2014
1Inflammation
02/2013
1Pancreatitis
09/2012
1Vascular Diseases (Vascular Disease)
08/2011
1Sudden Death
03/2008
1Diarrhea
07/2007
1Nasopharyngitis
07/2007
1Dyspepsia (Indigestion)
07/2007
1Respiratory Tract Infections (Respiratory Tract Infection)
07/2007
1Vomiting
03/2007
1Nausea
03/2007
1Peptic Ulcer (Peptic Ulcers)
03/2007
1Macular Edema
03/2007
1Hemorrhage
03/2007

Drug/Important Bio-Agent (IBA)

16LDL CholesterolIBA
11/2015 - 11/2002
14Lipoproteins (Lipoprotein)IBA
03/2015 - 11/2002
12Niacin (Nicotinic Acid)FDA LinkGeneric
01/2015 - 03/2002
12atorvastatin (Lipitor)FDA Link
10/2014 - 03/2003
11Triglycerides (Triacylglycerol)IBA
09/2012 - 07/2003
10CholesterolIBA
11/2015 - 11/2002
10HDL CholesterolIBA
11/2015 - 03/2003
9Simvastatin (Zocor)FDA LinkGeneric
09/2007 - 11/2002
8rosuvastatin (Crestor)FDA Link
10/2014 - 12/2002
8Glucose (Dextrose)FDA LinkGeneric
04/2014 - 07/2007
8ezetimibe (Zetia)FDA Link
12/2013 - 11/2002
7MK-0524IBA
01/2015 - 03/2008
6colesevelam (Welchol)FDA Link
01/2012 - 04/2006
5Pravastatin (Pravachol)FDA LinkGeneric
09/2007 - 12/2002
4Fenofibrate (CiL)FDA LinkGeneric
04/2011 - 04/2006
4Lovastatin (Mevacor)FDA LinkGeneric
09/2007 - 03/2002
3ApolipoproteinsIBA
03/2015 - 04/2008
3LipidsIBA
11/2014 - 02/2005
3Carbon MonoxideIBA
04/2014 - 04/2006
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
09/2012 - 03/2008
3Metformin (Glucophage)FDA LinkGeneric
01/2012 - 10/2008
3fenofibric acidFDA Link
09/2010 - 12/2008
2eicosapentaenoic acid ethyl esterIBA
05/2015 - 02/2013
2Creatine Kinase (Creatine Phosphokinase)IBA
11/2014 - 04/2006
21-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
02/2013 - 11/2011
2C-Reactive ProteinIBA
02/2013 - 04/2006
2Eicosapentaenoic AcidIBA
02/2013 - 01/2013
2Insulin (Novolin)FDA Link
01/2013 - 01/2012
2Hemoglobin AIBA
01/2012 - 10/2008
2EstersIBA
11/2011 - 07/2007
28- chloro- 2,3,4,5- tetrahydro- 1- methyl- 1H- 3- benzazepineIBA
03/2011 - 11/2009
2Serotonin (5 Hydroxytryptamine)IBA
03/2011 - 11/2009
2prostaglandin D2 receptorIBA
12/2009 - 11/2008
2Blood Glucose (Blood Sugar)IBA
01/2009 - 09/2007
2Fish OilsIBA
03/2008 - 03/2007
1xuezhikangIBA
11/2014
1Biological Markers (Surrogate Marker)IBA
11/2014
1TransaminasesIBA
11/2014
11- (glucopyranosyl)- 4- methyl- 3- (5- (4- fluorophenyl)- 2- thienylmethyl)benzeneIBA
04/2014
1SodiumIBA
04/2014
1Apolipoproteins B (ApoB)IBA
01/2014
1Adenosine Monophosphate (AMP)IBA
09/2013
1Protein Kinases (Protein Kinase)IBA
09/2013
1Adenosine Triphosphate (ATP)IBA
09/2013
1citrate (pro-3S)-lyaseIBA
09/2013
1oxidized low density lipoproteinIBA
02/2013
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2013
1Interleukin-6 (Interleukin 6)IBA
02/2013
1Fibric Acids (Fibrates)IBA
09/2012
1Apolipoprotein C-IIIIBA
11/2011
1VLDL CholesterolIBA
11/2011
1delta Opioid Receptors (delta Opioid Receptor)IBA
09/2011
15-HT2C Serotonin ReceptorIBA
11/2009
12- (4- (4- chlorobenzoyl)phenoxy)- 2- methylpropanoic acidIBA
02/2009
1Nonesterified Fatty Acids (NEFA)IBA
01/2009
1Prostaglandin D2IBA
11/2008
1remnant-like particle cholesterolIBA
04/2008
1fluvastatinFDA Link
09/2007
1OmacorFDA Link
07/2007
1OxidoreductasesIBA
03/2007
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2007
1Coenzyme A (CoA)IBA
03/2007
1Warfarin (Coumadin)FDA LinkGeneric
03/2007

Therapy/Procedure

3Drug Therapy (Chemotherapy)
03/2015 - 09/2014
1Blood Component Removal (Apheresis)
11/2014
1Bariatric Surgery
07/2013